Abstract
Several studies have been discussing the coexistence of glaucoma and ocular surface disease. In patients undergoing topical antiglaucomatous treatment, prevalences close to 50% were found, with correlation between symptoms and amount of antiglaucomatous drugs used. Although several recent studies have pointed to the correlation of ocular surface alterations secondary to toxicity of topica…